FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2016171875> ?p ?o ?g. }

• W2016171875 endingPage "438" @default.
• W2016171875 startingPage "428" @default.
• W2016171875 abstract "The use of α-emitting isotopes for radionuclide therapy is a promising treatment strategy for small micro-metastatic disease. The radioisotope (213)Bi is a nuclide that has found substantial use for targeted α-therapy (TAT). The relatively unexplored aqueous chemistry of Bi(3+), however, hinders the development of bifunctional chelating agents that can successfully deliver these Bi radioisotopes to the tumor cells. Here, a novel series of nitrogen-rich macrocyclic ligands is explored for their potential use as Bi-selective chelating agents.The ligands, 1,4,7,10-tetrakis(pyridin-2-ylmethyl)-1,4,7,10-tetraazacyclododecane (L(py)), 1,4,7,10-tetrakis(3-pyridazylmethyl)-1,4,7,10-tetraazacyclododecane (L(pyd)), 1,4,7,10-tetrakis(4-pyrimidylmethyl)-1,4,7,10-tetraazacyclododecane (L(pyr)), and 1,4,7,10-tetrakis(2-pyrazinylmethyl)-1,4,7,10-tetraazacyclododecane (L(pz)), were prepared by a previously reported method and investigated here for their abilities to bind Bi radioisotopes. The commercially available and commonly used ligands 1,4,7,10-tetraazacyclododecane-1,4,7,10-tetraacetic acid (DOTA) and N-[(R)-2-amino-3-(p-isothiocyanato-phenyl)propyl]-trans-(S,S)- cyclohexane-1,2-diamine-N,N,N',N,N-pentaacetic acid (CHX-A''-DTPA) were also explored for comparative purposes. Radio-thin-layer chromatography (TLC) was used to measure the binding kinetics and stabilities of the complexes formed. The long-lived isotope, (207)Bi (t(1/2)=32 years), was used for these studies. Density functional theory (DFT) calculations were also employed to probe the ligand interactions with Bi(3+) and the generator parent ion Ac(3+).In contrast to DOTA and CHX-A''-DTPA, these nitrogen-rich macrocycles selectively chelate Bi(3+) in the presence of the parent isotope Ac(3+). Among the four tested, L(py) was found to exhibit optimal Bi(3+)-binding kinetics and complex stability. L(py) complexes Bi(3+) more rapidly than DOTA, yet the resulting complexes are of similar stability. DFT calculations corroborate the experimentally observed selectivity of these ligands for Bi(3+) over Ac(3+).Taken together, these data implicate L(py) as a valuable chelating agent for the delivery of (213)Bi. Its selectivity for Bi(3+) and rapid and stable labeling properties warrant further investigation and biological studies." @default.
• W2016171875 created "2016-06-24" @default.
• W2016171875 creator A5009576211 @default.
• W2016171875 creator A5028023230 @default.
• W2016171875 creator A5031771161 @default.
• W2016171875 creator A5032434259 @default.
• W2016171875 creator A5036625940 @default.
• W2016171875 creator A5041785050 @default.
• W2016171875 creator A5046662341 @default.
• W2016171875 creator A5073167992 @default.
• W2016171875 creator A5075698508 @default.
• W2016171875 creator A5082499590 @default.
• W2016171875 creator A5084347846 @default.
• W2016171875 date "2015-05-01" @default.
• W2016171875 modified "2023-10-17" @default.
• W2016171875 title "Evaluation of nitrogen-rich macrocyclic ligands for the chelation of therapeutic bismuth radioisotopes" @default.
• W2016171875 cites W1950664582 @default.
• W2016171875 cites W1966335626 @default.
• W2016171875 cites W1967313063 @default.
• W2016171875 cites W1972256368 @default.
• W2016171875 cites W1974266836 @default.
• W2016171875 cites W1978689317 @default.
• W2016171875 cites W1979243488 @default.
• W2016171875 cites W1979278319 @default.
• W2016171875 cites W1979624352 @default.
• W2016171875 cites W1980796692 @default.
• W2016171875 cites W1980836254 @default.
• W2016171875 cites W1982424502 @default.
• W2016171875 cites W1983281046 @default.
• W2016171875 cites W1985046599 @default.
• W2016171875 cites W1988451067 @default.
• W2016171875 cites W1989444134 @default.
• W2016171875 cites W1997928845 @default.
• W2016171875 cites W2002972210 @default.
• W2016171875 cites W2007597828 @default.
• W2016171875 cites W2011215428 @default.
• W2016171875 cites W2014677876 @default.
• W2016171875 cites W2021050313 @default.
• W2016171875 cites W2021137787 @default.
• W2016171875 cites W2023073862 @default.
• W2016171875 cites W2023271753 @default.
• W2016171875 cites W2026419769 @default.
• W2016171875 cites W2027384015 @default.
• W2016171875 cites W2030167218 @default.
• W2016171875 cites W2030890093 @default.
• W2016171875 cites W2031360856 @default.
• W2016171875 cites W2033050479 @default.
• W2016171875 cites W2035018304 @default.
• W2016171875 cites W2035333853 @default.
• W2016171875 cites W2035535455 @default.
• W2016171875 cites W2037031765 @default.
• W2016171875 cites W2039719043 @default.
• W2016171875 cites W2041607504 @default.
• W2016171875 cites W2046412723 @default.
• W2016171875 cites W2047330854 @default.
• W2016171875 cites W2052163448 @default.
• W2016171875 cites W2053448830 @default.
• W2016171875 cites W2059886529 @default.
• W2016171875 cites W2060490522 @default.
• W2016171875 cites W2060695118 @default.
• W2016171875 cites W2061528942 @default.
• W2016171875 cites W2065451180 @default.
• W2016171875 cites W2071761375 @default.
• W2016171875 cites W2072324342 @default.
• W2016171875 cites W2072475957 @default.
• W2016171875 cites W2076801590 @default.
• W2016171875 cites W2077401632 @default.
• W2016171875 cites W2077752698 @default.
• W2016171875 cites W2078441657 @default.
• W2016171875 cites W2078569257 @default.
• W2016171875 cites W2089020309 @default.
• W2016171875 cites W2089660886 @default.
• W2016171875 cites W2091698425 @default.
• W2016171875 cites W2092315973 @default.
• W2016171875 cites W2094642658 @default.
• W2016171875 cites W2098590365 @default.
• W2016171875 cites W2102774138 @default.
• W2016171875 cites W2112884695 @default.
• W2016171875 cites W2114413057 @default.
• W2016171875 cites W2130650111 @default.
• W2016171875 cites W2135368140 @default.
• W2016171875 cites W2141104573 @default.
• W2016171875 cites W2143981217 @default.
• W2016171875 cites W2148086039 @default.
• W2016171875 cites W2156199289 @default.
• W2016171875 cites W2163887808 @default.
• W2016171875 cites W2167590372 @default.
• W2016171875 cites W2171140185 @default.
• W2016171875 cites W2316842651 @default.
• W2016171875 cites W2324373682 @default.
• W2016171875 cites W2327973838 @default.
• W2016171875 cites W2963847815 @default.
• W2016171875 cites W3105642836 @default.
• W2016171875 doi "https://doi.org/10.1016/j.nucmedbio.2014.12.007" @default.
• W2016171875 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/25684650" @default.
• W2016171875 hasPublicationYear "2015" @default.
• W2016171875 type Work @default.
• W2016171875 sameAs 2016171875 @default.

• next